BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
They have their fear of the platinum-based chemotherapy, which we try to alleviate, but a lot of patients just don't want it. But I do offer it to patients if they didn't receive it and they're eligible in the adjuvant setting, I do offer them cisplatinum-based chemotherapy. And I also offer it for upper tract patients, which, you know, we have protective data for that.
0
💬
0
Comments
Log in to comment.
There are no comments yet.